AbbVie Inc (ABBV)
87.03
+1.48 +1.73%
NYSE
Jan 17, 14:28
Delayed 2m
USD
View All Key Stats
ABBV Key Stats
| Income Statement | |
| Revenue (TTM) | 32.19B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 4.84 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 7.565B |
| Profitability | |
| Gross Profit Margin (Quarterly) | 77.72% |
| Profit Margin (Quarterly) | 33.35% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | Upgrade |
| Price and Valuation | |
| Market Cap | 130.91B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 4.251 |
| PE Ratio (TTM) | 17.98 |
| Price to Book Value | -- |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | Upgrade |
| Free Cash Flow (Quarterly) | 4.242B |
| Return on Equity (TTM) | Upgrade |
View All ABBV News
ABBV News
-
WireHeadlineTime (ET)
-
Yahoo01/17 09:15
-
Yahoo01/17 08:48
-
Yahoo01/17 08:04
-
Yahoo01/17 07:00
-
Yahoo01/16 16:26
-
Yahoo01/16 15:04
-
Yahoo01/16 12:28
-
SA Breaking News01/16 12:20
-
SA Breaking News01/16 11:26
-
SA Breaking News01/16 07:43
View All Events
ABBV Events
| Date | Type | Description |
|---|---|---|
| 04/26/2019 08:00 CDT | Misc | AbbVie Inc First Quarter Earnings Conference Call in 2019 |
| 04/26/2019 | Earnings | AbbVie Inc First Quarter Earnings in 2019 Release |
| 01/25/2019 08:00 CST | Misc | AbbVie Inc Fourth Quarter Earnings Conference Call in 2018 |
| 01/25/2019 | Earnings | AbbVie Inc Fourth Quarter Earnings in 2018 Release |
| 01/14/2019 | Dividends | Amount: 1.07, Declared Date: Nov 02 2018, Pay Date: Feb 15 2019 |
| 11/02/2018 08:00 CDT | Misc | AbbVie Inc Third Quarter Earnings Conference Call in 2018 |
| 11/02/2018 | Earnings | AbbVie Inc Third Quarter Earnings in 2018 Release |
| 10/12/2018 | Dividends | Amount: 0.96, Declared Date: Sep 07 2018, Pay Date: Nov 15 2018 |
| 07/27/2018 09:00 EDT | Misc | AbbVie Inc Second Quarter Earnings Conference Call in 2018 |
| 07/27/2018 | Earnings | AbbVie Inc Second Quarter Earnings Results in 2018 |
ABBV Fundamentals
Income Statement View Statement
ABBV Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
ABBV One Page Reports
- One Page Report Download
ABBV Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 87.03 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Edit
Profile
- URL: http://www.abbvie.com
- Investor Relations URL: http://www.abbvieinvestor.com/phoenix.zhtml?c=251551&p=irol-IRHome
- HQ State/Province: Illinois
- Sector: Healthcare
- Industry: Drug Manufacturers - Major
- Equity Style: Large Cap/Blend
- Next Earnings Release: Jan. 25, 2019
- Last Earnings Release: Nov. 02, 2018
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: Jan. 14, 2019
- Description: AbbVie Inc is a biopharmaceutical company that discovers, develops, manufactures and sells a range of pharmaceutical products for treating chronic autoimmune diseases, virology and neurological disorders.
ABBV Excel Add-In Codes
- Name: =YCI("ABBV","name")
- Description: =YCI("ABBV","description")
- Sector: =YCI("ABBV","sector")
- Industry: =YCI("ABBV","industry")
- Est. Current Fiscal Year End: =YCI("ABBV","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other ABBV Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- ABBV Tweets Stocktwits
Advertisement
